These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31529628)

  • 1. Pharmacokinetics of a modified, compounded theophylline product in dogs.
    Cavett CL; Li Z; McKiernan BC; Reinhart JM
    J Vet Pharmacol Ther; 2019 Nov; 42(6):593-601. PubMed ID: 31529628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidose pharmacokinetics and safety of a modified, compounded theophylline product in dogs.
    Reinhart JM; Perkowski C; Lester C; Campos V; Kadotani S; Li Z; McKiernan BC; Fries R
    J Vet Pharmacol Ther; 2021 Nov; 44(6):902-909. PubMed ID: 34173985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the bioavailability and pharmacokinetics of two extended-release theophylline formulations in dogs.
    Bach JE; Kukanich B; Papich MG; McKiernan BC
    J Am Vet Med Assoc; 2004 Apr; 224(7):1113-9. PubMed ID: 15074856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of a 503B outsourcing facility-produced theophylline in dogs.
    Reinhart JM; de Oliveira GAR; Forsythe L; Li Z
    PLoS One; 2022; 17(1):e0262336. PubMed ID: 34990472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enrofloxacin-theophylline interaction: influence of enrofloxacin on theophylline steady-state pharmacokinetics in the beagle dog.
    Intorre L; Mengozzi G; Maccheroni M; Bertini S; Soldani G
    J Vet Pharmacol Ther; 1995 Oct; 18(5):352-6. PubMed ID: 8587153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of an extended-release theophylline product in cats.
    Guenther-Yenke CL; McKiernan BC; Papich MG; Powell E
    J Am Vet Med Assoc; 2007 Sep; 231(6):900-6. PubMed ID: 17867974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The disposition of theophylline in camels after intravenous administration.
    Wasfi IA; Elghazali M; Boni NS; Hadi AA; Alhadrami GA; Almuhrami AM; Alkatheeri NA; Barezaiq IM; Agha BA; Wajid SA
    J Vet Pharmacol Ther; 1999 Aug; 22(4):255-60. PubMed ID: 10499237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theophylline controlled-release formulations: in vivo-in vitro correlations.
    Yu Z; Schwartz JB; Sugita ET
    Biopharm Drug Dispos; 1996 Apr; 17(3):259-72. PubMed ID: 8983400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of a pharmacokinetic interaction between lansoprazole or pantoprazole and theophylline.
    Pan WJ; Goldwater DR; Zhang Y; Pilmer BL; Hunt RH
    Aliment Pharmacol Ther; 2000 Mar; 14(3):345-52. PubMed ID: 10735929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Population pharmacokinetic analysis of two theophylline formulations in premature neonates and infants with apnea].
    Suda Y; Hanada K; Tsuchiwata S; Saito M; Nakamura T; Ito Y; Ishikawa Y; Kushida K; Ogata H
    Yakugaku Zasshi; 2008 Apr; 128(4):635-40. PubMed ID: 18379181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of montelukast on single-dose theophylline pharmacokinetics.
    Malmstrom K; Schwartz J; Reiss TF; Sullivan TJ; Reese JH; Jauregui L; Miller K; Scott M; Shingo S; Peszek I; Larson P; Ebel D; Hunt TL; Huhn RD; Bachmann K
    Am J Ther; 1998 May; 5(3):189-95. PubMed ID: 10099058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theophylline concentration following equal doses of intravenous aminophylline and oral theophylline in preterm infants.
    al-Omran A; al-Alaiyan S
    Am J Perinatol; 1997 Mar; 14(3):147-9. PubMed ID: 9259917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic properties of theophylline given intravenously and orally to ruminating calves.
    Langston VC; Koritz GD; Davis LE; Neff-Davis C
    Am J Vet Res; 1989 Apr; 50(4):493-7. PubMed ID: 2712416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of a pharmacokinetic interaction between intravenous theophylline and orally administered levofloxacin.
    Gisclon LG; Curtin CR; Fowler CL; Williams RR; Hafkin B; Natarajan J
    J Clin Pharmacol; 1997 Aug; 37(8):744-50. PubMed ID: 9378847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic studies of theophylline in dogs.
    McKiernan BC; Neff-Davis CA; Koritz GD; Davis LE; Pheris DR
    J Vet Pharmacol Ther; 1981 Jun; 4(2):103-10. PubMed ID: 7349323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of orally administered marbofloxacin on the pharmacokinetics of theophylline.
    Hirt RA; Teinfalt M; Dederichs D; van den Hoven R
    J Vet Med A Physiol Pathol Clin Med; 2003 Jun; 50(5):246-50. PubMed ID: 14567511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronopharmacokinetics of theophylline administered as a controlled-release tablet.
    Thielemann AM; Manquez N; Pinilla E; Gai MN; Romero P; Arancibia A; Chavez H
    Int J Clin Pharmacol Ther; 1996 Mar; 34(3):130-3. PubMed ID: 8705090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individualization of theophylline infusion rate on the basis of a nonlinear compartmental pharmacokinetic model.
    Nikiforidis GC; Argyropoulos CP; Kassimatis TI; Ithakissios DS
    Eur J Drug Metab Pharmacokinet; 1997; 22(3):265-76. PubMed ID: 9358209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of the theophylline pharmacokinetics of sustained-release theophylline (Theodur) dry syrup in children].
    Okuma M; Iikura Y
    Arerugi; 1999 Jun; 48(6):589-96. PubMed ID: 10423899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.